Our History
In 2012, the entrepreneurial project of the third generation of the de Laurentiis family came to life. With great pride, Dr. Antonio and Dr. Caterina De Laurentiis founded ADL Farmaceutici, a company that invests in the Nutraceutical segment . With an innovative and professional spirit, with a strategy strongly oriented towards the market and the satisfaction of end consumers. The company is committed every day to developing products characterized by a high technical-scientific content and high certified quality standards, such as to ensure maximum efficacy, tolerability and safety to the medical class and patients.
2012
FOUNDATION
Antonio De Laurentiis founds ADL Farmaceutici, a company that invests in the Nutraceuticals and Functional Cosmetics segment.
2013
THE OLINORM LINE IS BORN
The company launches the first product of the Olinorm line, which will become the market leader in Campania.
2019
Incarico di consulenza per lo sviluppo e registrazione conto terzi di un pacchetto di dispositivi medici di classe 2 per conto della New.Fadem srl
2020
PATENTS AND
ISO 13485 CERTIFICATION
Obtaining 2 international patents: one for the respiratory field and one for the gynecological field.
Obtaining ISO 13485 certification
2021
Creation of the DEL&BAS PHARMA Holding and subsequent rounds of capital increases.
2022
HARMONIUM PHARMA
Acquisition of Harmonium Pharma (diabetes) and Sinergy Pharma (oral care)
2023
Creation of a strategic JV with the Polish multinational USP Group
2024
PHARMAIDEA & SEID LAB
Distribution agreement with Pharmaidea and Seid Lab (licensees)
Mission & Values
Our mission is to design, formulate and register innovative medical devices, supplements and cosmetics.
in market niches that present opportunities for technological development.
EXPERIENCE
The experience handed down through three generations significantly enriches the technical-scientific and commercial background.
PROFESSIONALISM
By directly following all the life stages of our products, from the study to the improvement of the formula, from the production and processing process to the packaging, from the placing on the market to its control on the market, we carry out our activity with great competence and efficiency.
INTEGRITY
By actively and intensively participating in every phase of development and testing of our products, we are able to fully enhance the efficacy, tolerability and safety that derive from them.
INNOVATION
Starting from an accurate and in-depth study of the needs of patients, of the clinical data collected, of the latest news in pharmaceutical technology and from the comparison with experts in the scientific field and from the collaboration with international partners, innovative and cutting-edge formulations are born.
COMPARISON
The daily comparison with the major national experts in the scientific field allows us to always be updated on potential market developments, new formulations, new trends and new regulations.
RESPECT
We are a company recognized by the Italian pharmaceutical market and by the Medical Class. Aware of this reality and the great expectations towards us, we always give our best, committing ourselves to guaranteeing constant standards of excellence over time.